138 related articles for article (PubMed ID: 33218683)
21. Antivirals of ethnomedicinal origin: structure-activity relationship and scope.
Chattopadhyay D; Naik TN
Mini Rev Med Chem; 2007 Mar; 7(3):275-301. PubMed ID: 17346219
[TBL] [Abstract][Full Text] [Related]
22. A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists.
Liu B; Tang L; Zhang X; Ma J; Sehgal M; Cheng J; Zhang X; Zhou Y; Du Y; Kulp J; Guo JT; Chang J
Antiviral Res; 2017 Nov; 147():37-46. PubMed ID: 28982551
[TBL] [Abstract][Full Text] [Related]
23. Antivirals against animal viruses.
Villa TG; Feijoo-Siota L; Rama JLR; Ageitos JM
Biochem Pharmacol; 2017 Jun; 133():97-116. PubMed ID: 27697545
[TBL] [Abstract][Full Text] [Related]
24. Cryo-EM structure of eastern equine encephalitis virus in complex with heparan sulfate analogues.
Chen CL; Hasan SS; Klose T; Sun Y; Buda G; Sun C; Klimstra WB; Rossmann MG
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):8890-8899. PubMed ID: 32245806
[TBL] [Abstract][Full Text] [Related]
25. Novel N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives as potent and selective influenza virus fusion inhibitors.
Göktaş F; Özbil M; Cesur N; Vanderlinden E; Naesens L; Cesur Z
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900028. PubMed ID: 31531897
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B protein.
Tai VW; Garrido D; Price DJ; Maynard A; Pouliot JJ; Xiong Z; Seal JW; Creech KL; Kryn LH; Baughman TM; Peat AJ
Bioorg Med Chem Lett; 2014 May; 24(10):2288-94. PubMed ID: 24731273
[TBL] [Abstract][Full Text] [Related]
27. Antiviral activity of N, N'-dimethyl-epidithiapiperazinedione, a synthetic compound related to the gliotoxins, LL-S88alpha and beta, chetomin and the sporidesmins.
Trown PW
Biochem Biophys Res Commun; 1968 Nov; 33(3):402-7. PubMed ID: 5722231
[No Abstract] [Full Text] [Related]
28. Antiphage activity of natural and synthetic substances: a new age for antivirals?
Ribeiro JM; Pereira GN; Kobayashi RK; Nakazato G
Future Microbiol; 2020 Jun; 15():767-777. PubMed ID: 32700548
[TBL] [Abstract][Full Text] [Related]
29. Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugs.
Naesens L; Zoulim F
Curr Opin Virol; 2017 Jun; 24():v-vii. PubMed ID: 28743435
[No Abstract] [Full Text] [Related]
30. [Mechanisms of the effect of antiviral agents].
Holý A
Cas Lek Cesk; 1993 Jan; 132(1):12-7. PubMed ID: 8435843
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic assessment of antiviral activity for spiro-annulated oxepanes and azepenes.
Osolodkin DI; Kozlovskaya LI; Iusupov IR; Kurkin AV; Shustova EY; Orlov AA; Khvatov EV; Mutnykh ES; Kurashova SS; Vetrova AN; Yatsenko DO; Goryashchenko AS; Ivanov VN; Lukyanenko ER; Karpova EV; Stepanova DA; Volok VP; Sotskova SE; Dzagurova TK; Karganova GG; Lukashev AN; Ishmukhametov AA
Chem Biol Drug Des; 2024 May; 103(5):e14553. PubMed ID: 38789394
[TBL] [Abstract][Full Text] [Related]
32. Heparan sulfate chains from glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural differences.
Tumova S; Woods A; Couchman JR
J Biol Chem; 2000 Mar; 275(13):9410-7. PubMed ID: 10734086
[TBL] [Abstract][Full Text] [Related]
33. Exploration of (hetero)aryl Derived Thienylchalcones for Antiviral and Anticancer Activities.
Patil V; Patil SA; Patil R; Bugarin A; Beaman K; Patil SA
Med Chem; 2019; 15(2):150-161. PubMed ID: 29792154
[TBL] [Abstract][Full Text] [Related]
34. Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum.
Martínez-Gualda B; Sun L; Martí-Marí O; Mirabelli C; Delang L; Neyts J; Schols D; Camarasa MJ; San-Félix A
Antiviral Res; 2019 Aug; 168():210-214. PubMed ID: 31228490
[TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71.
Pourianfar HR; Poh CL; Fecondo J; Grollo L
Virus Res; 2012 Oct; 169(1):22-9. PubMed ID: 22771616
[TBL] [Abstract][Full Text] [Related]
36. Novel non-nucleoside human cytomegalovirus inhibitors based upon TSAO nucleoside derivatives: structure-activity relationships.
de Castro S; Andrei G; Snoeck R; Balzarini J; Camarasa MJ; Velázquez S
Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):625-8. PubMed ID: 18066868
[TBL] [Abstract][Full Text] [Related]
37. Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
Xu Y; Martinez P; Séron K; Luo G; Allain F; Dubuisson J; Belouzard S
J Virol; 2015 Apr; 89(7):3846-58. PubMed ID: 25609801
[TBL] [Abstract][Full Text] [Related]
38. Design, Synthesis, and Preliminary Studies of Spiro-isoxazoline-peroxides against Human Cytomegalovirus and Glioblastoma ∥.
Das P; Hasan MH; Mitra D; Bollavarapu R; Valente EJ; Tandon R; Raucher D; Hamme AT
J Org Chem; 2019 Jun; 84(11):6992-7006. PubMed ID: 31066280
[TBL] [Abstract][Full Text] [Related]
39. Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis.
Rusnati M; Urbinati C
Curr Pharm Des; 2009; 15(25):2946-57. PubMed ID: 19754371
[TBL] [Abstract][Full Text] [Related]
40. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.
Witvrouw M; De Clercq E
Gen Pharmacol; 1997 Oct; 29(4):497-511. PubMed ID: 9352294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
